艾利丹尼森美股招股说明书(2025-09-09版)

4.000% Senior Notes due 2035 We are offering €500,000,000 aggregate principal amount of 4.000%Senior Notes due 2035 (the “notes”). Interest on the notes will be payableannually in arrears on September11 of each year, beginning September11, 2026. The notes will mature on September11, 2035 unless redeemed prior tothat date. We may redeem all or part of the notes at any time or from time to time prior to maturity at the redemption price specified in this prospectussupplement. In the event of a Change of Control Triggering Event as described herein, the holders of the notes may require us to purchase all or part oftheir notes at the purchase price specified in this prospectus supplement. The notes will be our unsecured and unsubordinated obligations and will rank equally with all of our other unsecured and unsubordinatedindebtedness and other liabilities from time to time outstanding. The notes will be structurally subordinated to all indebtedness and other liabilities ofour subsidiaries. The notes are new issues of securities with no established trading market. Currently, there is no public market for the notes. We intend to apply tolist the notes on the Nasdaq Global Market (“Nasdaq”). The notes will be issued in minimum denominations of €100,000 and integral multiples of€1,000 in excess thereof. Investing in the notes involves risks that are described in the “Risk Factors” section of this prospectus supplementbeginning on pageS-6 of this prospectus supplement. (1)Plus accrued interest from September11, 2025, if settlement occurs after that date. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities ordetermined that this prospectus supplement or the accompanying prospectus is accurate or complete. Any representation to the contrary is acriminal offense. The underwriters expect to deliver the notes in book-entry form only through the facilities of Euroclear Bank S.A./N.V. (“Euroclear”) andClearstream Banking,société anonyme(“Clearstream”), on or about September11, 2025. Mizuho Table of Contents You should rely only on the information contained or incorporated or deemed to be incorporated by reference in this prospectussupplement, the accompanying prospectus and any free writing prospectus that we may provide to you. Neither we nor the underwriters haveauthorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, youshould not rely on it. Neither we nor the underwriters are making an offer to sell these securities in any jurisdiction where the offer or sale isnot permitted. You should assume that the information appearing in this prospectus supplement, the accompanying prospectus and any freewriting prospectus is accurate as of the date on its respective cover, and that any information incorporated by reference is accurate only as ofthe date of the document incorporated by reference, unless we indicate otherwise. Our business, financial condition, results of operations, cashflows and prospects may have changed since those dates. Table of Contents Prospectus Supplement About this Prospectus SupplementForward-Looking StatementsIncorporation of Documents by ReferenceSummaryThe OfferingSummary Financial DataRisk FactorsUse of ProceedsCurrency ConversionCapitalizationDescription of the NotesCertain ERISA ConsiderationsMaterial U.S. Federal Income Tax ConsiderationsUnderwritingLegal MattersExperts Prospectus ABOUT THIS PROSPECTUSRISK FACTORSWHERE YOU CAN FIND MORE INFORMATIONINCORPORATION OF CERTAIN DOCUMENTS BY REFERENCEFORWARD-LOOKING STATEMENTSAVERY DENNISON CORPORATIONUSE OF PROCEEDSDESCRIPTION OF SECURITIESDESCRIPTION OF COMMON STOCK AND PREFERRED STOCKVALIDITY OF THE SECURITIESEXPERTS Table of Contents About this Prospectus Supplement This document has two parts. The first part, which is the prospectus supplement, describes the specific terms of the offering and the notes offered.The second part, which is the accompanying prospectus, gives more general information, some of which may not apply to the offering. If the descriptionof the offering varies between this prospectus supplement and the accompanying prospectus, you should rely on the information in this prospectussupplement. Before purchasing any of the notes, you should carefully read both this prospectus supplement and the accompanying prospectus, together withthe additional information described in this prospectus supplement under “Incorporation of Documents by Reference” and in the accompanyingprospectus under “Where You Can Find More Information” and “Incorporation of Documents by Reference.” You should rely only on the information we provide or incorporate by reference in this prospectus supplement and the accompanying prospectus.Neither we nor the underwriters have authorized any other person to provide you with different information. We are offering to sell the notes offered by